---
pmid: '32839608'
title: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and
  inflammation.
authors:
- Ng SS
- De Labastida Rivera F
- Yan J
- Corvino D
- Das I
- Zhang P
- Kuns R
- Chauhan SB
- Hou J
- Li XY
- Frame TCM
- McEnroe BA
- Moore E
- Na J
- Engel JA
- Soon MSF
- Singh B
- Kueh AJ
- Herold MJ
- Montes de Oca M
- Singh SS
- Bunn PT
- Aguilera AR
- Casey M
- Braun M
- Ghazanfari N
- Wani S
- Wang Y
- Amante FH
- Edwards CL
- Haque A
- Dougall WC
- Singh OP
- Baxter AG
- Teng MWL
- Loukas A
- Daly NL
- Cloonan N
- Degli-Esposti MA
- Uzonna J
- Heath WR
- Bald T
- Tey SK
- Nakamura K
- Hill GR
- Kumar R
- Sundar S
- Smyth MJ
- Engwerda CR
journal: Nat Immunol
year: '2020'
full_text_available: false
pmcid: PMC7965849
doi: 10.1038/s41590-020-0758-6
---

# The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.
**Authors:** Ng SS, De Labastida Rivera F, Yan J, Corvino D, Das I, Zhang P, Kuns R, Chauhan SB, Hou J, Li XY, Frame TCM, McEnroe BA, Moore E, Na J, Engel JA, Soon MSF, Singh B, Kueh AJ, Herold MJ, Montes de Oca M, Singh SS, Bunn PT, Aguilera AR, Casey M, Braun M, Ghazanfari N, Wani S, Wang Y, Amante FH, Edwards CL, Haque A, Dougall WC, Singh OP, Baxter AG, Teng MWL, Loukas A, Daly NL, Cloonan N, Degli-Esposti MA, Uzonna J, Heath WR, Bald T, Tey SK, Nakamura K, Hill GR, Kumar R, Sundar S, Smyth MJ, Engwerda CR
**Journal:** Nat Immunol (2020)
**DOI:** [10.1038/s41590-020-0758-6](https://doi.org/10.1038/s41590-020-0758-6)
**PMC:** [PMC7965849](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965849/)

## Abstract

1. Nat Immunol. 2020 Oct;21(10):1205-1218. doi: 10.1038/s41590-020-0758-6. Epub 
2020 Aug 24.

The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and 
inflammation.

Ng SS(1)(2)(3), De Labastida Rivera F(1), Yan J(1)(4), Corvino D(1)(4)(3), Das 
I(1), Zhang P(1), Kuns R(1), Chauhan SB(5), Hou J(1), Li XY(1), Frame TCM(1)(4), 
McEnroe BA(1), Moore E(1)(4), Na J(1)(4), Engel JA(1), Soon MSF(1)(4), Singh 
B(5), Kueh AJ(6)(7), Herold MJ(6)(7), Montes de Oca M(1), Singh SS(5), Bunn 
PT(1)(8), Aguilera AR(1), Casey M(1), Braun M(1), Ghazanfari N(9), Wani 
S(1)(10), Wang Y(1)(2), Amante FH(1), Edwards CL(1)(4), Haque A(1), Dougall 
WC(1), Singh OP(11), Baxter AG(12), Teng MWL(1), Loukas A(13), Daly NL(13), 
Cloonan N(1)(14), Degli-Esposti MA(15)(16), Uzonna J(17), Heath WR(9), Bald 
T(1), Tey SK(1), Nakamura K(1), Hill GR(18), Kumar R(5)(19), Sundar S(#)(5), 
Smyth MJ(#)(1), Engwerda CR(#)(20).

Author information:
(1)QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
(2)School of Environment and Science, Griffith University, Nathan, Queensland, 
Australia.
(3)Institute of Experimental Oncology, Medical Faculty, University Hospital 
Bonn, University of Bonn, Bonn, Germany.
(4)School of Medicine, University of Queensland, Brisbane, Queensland, 
Australia.
(5)Department of Medicine, Institute of Medical Sciences, Banaras Hindu 
University, Varanasi, India.
(6)Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute of 
Medical Research, Melbourne, Victoria, Australia.
(7)Department of Medical Biology, University of Melbourne, Melbourne, Victoria, 
Australia.
(8)Institute of Glycomics, Griffith University, Gold Coast, Queensland, 
Australia.
(9)Department of Microbiology and Immunology, The Peter Doherty Institute, 
University of Melbourne, Melbourne, Victoria, Australia.
(10)Institute of Molecular Biology, University of Queensland, Brisbane, 
Queensland, Australia.
(11)Department of Biochemistry, Institute of Science, Banaras Hindu University, 
Varanasi, India.
(12)College of Public Health, Medical and Veterinary Sciences, James Cook 
University, Townsville, Queensland, Australia.
(13)Australian Institute of Tropical Health and Medicine, James Cook University, 
Cairns, Queensland, Australia.
(14)Faculty of Science, University of Auckland, Auckland, New Zealand.
(15)Infection and Immunity Program and Department of Microbiology, Biomedicine 
Discovery Institute, Monash University, Melbourne, Victoria, Australia.
(16)The Centre for Experimental Immunology, Lions Eye Institute, Perth, Western 
Australia, Australia.
(17)Department of Immunology, Max Rady College of Medicine, University of 
Manitoba, Winnipeg, Manitoba, Canada.
(18)Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, 
WA, USA.
(19)Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, 
Banaras Hindu University, Varanasi, India.
(20)QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. 
chrisE@qimr.edu.au.
(#)Contributed equally

Erratum in
    Nat Immunol. 2024 Apr;25(4):716. doi: 10.1038/s41590-024-01770-8.

Comment in
    Nat Immunol. 2020 Oct;21(10):1139-1140. doi: 10.1038/s41590-020-0767-5.
    Immunol Cell Biol. 2020 Nov;98(10):802-804. doi: 10.1111/imcb.12403.

Immune-modulating therapies have revolutionized the treatment of chronic 
diseases, particularly cancer. However, their success is restricted and there is 
a need to identify new therapeutic targets. Here, we show that natural killer 
cell granule protein 7 (NKG7) is a regulator of lymphocyte granule exocytosis 
and downstream inflammation in a broad range of diseases. NKG7 expressed by CD4+ 
and CD8+ T cells played key roles in promoting inflammation during visceral 
leishmaniasis and malaria-two important parasitic diseases. Additionally, NKG7 
expressed by natural killer cells was critical for controlling cancer 
initiation, growth and metastasis. NKG7 function in natural killer and CD8+ T 
cells was linked with their ability to regulate the translocation of CD107a to 
the cell surface and kill cellular targets, while NKG7 also had a major impact 
on CD4+ T cell activation following infection. Thus, we report a novel 
therapeutic target expressed on a range of immune cells with functions in 
different immune responses.

DOI: 10.1038/s41590-020-0758-6
PMCID: PMC7965849
PMID: 32839608 [Indexed for MEDLINE]

Conflict of interest statement: Competing interests The authors declare no 
competing interests.
